PrairieView Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-108
Closed -$62K – 476
2023
Q1
$62K Hold
108
– – 0.01% 170
2022
Q4
$59K Hold
108
– – 0.01% 176
2022
Q3
$55K Sell
108
-27
-20% -$15.1K 0.01% 170
2022
Q2
$73K Hold
135
– – 0.01% 162
2022
Q1
$80K Hold
135
– – 0.01% 165
2021
Q4
$90K Buy
135
+108
+400% +$67.4K 0.01% 160
2021
Q3
$15K Hold
27
– – ﹤0.01% 248
2021
Q2
$14K Hold
27
– – ﹤0.01% 251
2021
Q1
$12K Buy
+27
New +$12.9K ﹤0.01% 259

Other funds holding TMO

PrairieView Partners's TMO Position: Q2 2023 in Review

PrairieView Partners sold out of Thermo Fisher Scientific (TMO) in Q2 2023, closing a stake of 108 shares — an estimated $62K sold.

PrairieView Partners first reported a position in TMO in Q1 2021 and held it in 9 quarters. The position peaked at $90K in Q4 2021. 2,388 funds tracked by Wall St. Rank hold TMO as of Q2 2023.

  • PrairieView Partners reported no remaining Thermo Fisher Scientific position as of Q2 2023 after selling out during the quarter.
  • PrairieView Partners sold 108 Thermo Fisher Scientific shares in Q2 2023, an estimated $62K.
  • PrairieView Partners first reported a position in Thermo Fisher Scientific in Q1 2021 and held it in 9 quarters.
  • PrairieView Partners's Thermo Fisher Scientific position peaked at $90K in Q4 2021.
  • 2,388 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2023.

Based on PrairieView Partners's 13F filing for Q2 2023, filed 4 Aug 2023.